Related Experiment Video
Updated: Nov 28, 2025

06:38
Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines
Published on: November 8, 2011
40.9K
Successful hematopoietic stem cell transplantation in a 4-1BB deficient patient with EBV-induced lymphoproliferation
Christine Wildermann1, Mohammed Alosaimi2, Sophie Liebenehm1
1Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Germany.
Clinical Immunology (Orlando, Fla.)
|December 1, 2020
Complete remission from recurrent EBV-positive lymphoma is not mandatory before HSCT to achieve long-term cure in a patient suffering from a recently described immunodeficiency affecting the T-cell coactivation molecule 4-1BB.
Complete remission from recurrent EBV-positive lymphoma is not mandatory before HSCT to achieve long-term cure in a patient suffering from a recently described immunodeficiency affecting the T-cell coactivation molecule 4-1BB.

